NV5 Global Statistics
Total Valuation
Amgen has a market cap or net worth of BRL 838.42 billion. The enterprise value is 1.10 trillion.
Market Cap | 838.42B |
Enterprise Value | 1.10T |
Important Dates
The last earnings date was Monday, August 4, 2025.
Earnings Date | Aug 4, 2025 |
Ex-Dividend Date | May 15, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.19% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 536.32M |
Valuation Ratios
The trailing PE ratio is 23.25 and the forward PE ratio is 13.81.
PE Ratio | 23.25 |
Forward PE | 13.81 |
PS Ratio | 4.41 |
PB Ratio | 20.72 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.38, with an EV/FCF ratio of 19.08.
EV / Earnings | 30.56 |
EV / Sales | 5.76 |
EV / EBITDA | 12.38 |
EV / EBIT | 18.91 |
EV / FCF | 19.08 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 7.57.
Current Ratio | 1.31 |
Quick Ratio | 0.82 |
Debt / Equity | 7.57 |
Debt / EBITDA | 3.46 |
Debt / FCF | 5.30 |
Interest Coverage | 3.09 |
Financial Efficiency
Return on equity (ROE) is 99.14% and return on invested capital (ROIC) is 10.06%.
Return on Equity (ROE) | 99.14% |
Return on Assets (ROA) | 7.44% |
Return on Invested Capital (ROIC) | 10.06% |
Return on Capital Employed (ROCE) | 15.79% |
Revenue Per Employee | 6.79M |
Profits Per Employee | 1.29M |
Employee Count | 28,000 |
Asset Turnover | 0.39 |
Inventory Turnover | 1.47 |
Taxes
In the past 12 months, Amgen has paid 4.39 billion in taxes.
Income Tax | 4.39B |
Effective Tax Rate | 10.84% |
Stock Price Statistics
The stock price has decreased by -12.02% in the last 52 weeks. The beta is 0.48, so Amgen's price volatility has been lower than the market average.
Beta (5Y) | 0.48 |
52-Week Price Change | -12.02% |
50-Day Moving Average | 58.02 |
200-Day Moving Average | 59.73 |
Relative Strength Index (RSI) | 35.88 |
Average Volume (20 Days) | 57 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 5.67 |
Income Statement
In the last 12 months, Amgen had revenue of BRL 190.26 billion and earned 36.07 billion in profits. Earnings per share was 66.64.
Revenue | 190.26B |
Gross Profit | 131.96B |
Operating Income | 58.00B |
Pretax Income | 40.45B |
Net Income | 36.07B |
EBITDA | 87.48B |
EBIT | 58.00B |
Earnings Per Share (EPS) | 66.64 |
Balance Sheet
The company has 43.74 billion in cash and 306.24 billion in debt, giving a net cash position of -262.50 billion.
Cash & Cash Equivalents | 43.74B |
Total Debt | 306.24B |
Net Cash | -262.50B |
Net Cash Per Share | n/a |
Equity (Book Value) | 40.47B |
Book Value Per Share | 75.19 |
Working Capital | 34.10B |
Cash Flow
In the last 12 months, operating cash flow was 65.46 billion and capital expenditures -7.67 billion, giving a free cash flow of 57.78 billion.
Operating Cash Flow | 65.46B |
Capital Expenditures | -7.67B |
Free Cash Flow | 57.78B |
FCF Per Share | n/a |
Margins
Gross margin is 69.36%, with operating and profit margins of 30.48% and 18.96%.
Gross Margin | 69.36% |
Operating Margin | 30.48% |
Pretax Margin | 21.26% |
Profit Margin | 18.96% |
EBITDA Margin | 45.98% |
EBIT Margin | 30.48% |
FCF Margin | 30.37% |
Dividends & Yields
This stock pays an annual dividend of 1.29, which amounts to a dividend yield of 2.20%.
Dividend Per Share | 1.29 |
Dividend Yield | 2.20% |
Dividend Growth (YoY) | 20.27% |
Years of Dividend Growth | 11 |
Payout Ratio | 75.15% |
Buyback Yield | -0.19% |
Shareholder Yield | 2.02% |
Earnings Yield | 4.30% |
FCF Yield | 6.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on October 29, 2020. It was a forward split with a ratio of 28.
Last Split Date | Oct 29, 2020 |
Split Type | Forward |
Split Ratio | 28 |
Scores
Amgen has an Altman Z-Score of 1.68 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.68 |
Piotroski F-Score | 7 |